Pharmacological Group
Latin name
Amphotericinum в [liposomalum] ( Amphotericini в [liposomali]).
Used in the treatment of
- R50.9 Fever, unspecified
- D70 Agranulocytosis
- B55.0 Visceral leishmaniasis
- B49 Unspecified mycosis
- B46 Zygomycosis
- B45.1 Cerebral cryptococcosis
- B44 Aspergillosis
- B41.9 Paracoccidioidomycosis, unspecified
- B39 Histoplasmosis
- B40 Blastomycosis
- B37.9 Candidiasis, unspecified
- B38.9 Coccidioidomycosis, unspecified
- B45.9 Cryptococcosis, unspecified
- B55.2 Mucocutaneous leishmaniasis
Included in the composition
- — Ambisome (4 firms)
- — Amphotericin B Liposomal (2 firms)